{"DataElement":{"publicId":"3135596","version":"1","preferredName":"Trastuzumab Agent Discontinue Administration Reason","preferredDefinition":"the trial-specific reason why treatment with trastuzumab, a humanized recombinant monoclonal antibody directed against the HER2- receptor protein, ended prematurely or did not begin.","longName":"3135595v1.0:2390912v1.0","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"3135595","version":"1","preferredName":"Trastuzumab Agent Discontinue Administration","preferredDefinition":"information related to the cessation of administering trastuzumab, a humanized recombinant monoclonal antibody directed against the HER2- receptor protein.","longName":"2322168v1.0:2207230v1.0","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2322168","version":"1","preferredName":"Trastuzumab Agent","preferredDefinition":"A humanized recombinant monoclonal antibody directed against the HER2- receptor protein.  Trastuzumab binds to the extracellular domain of the growth factor protein HER2, thereby inhibiting proliferation of HER2 overexpressing tumor cells.  Binding with HER2 protein also initiates an antibody-dependent cell cytotoxicity.(NCI):An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect. (NCI)","longName":"C1647:C1708","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Trastuzumab","conceptCode":"C1647","definition":"A recombinant humanized monoclonal antibody directed against the human epidermal growth factor receptor 2 (HER2). After binding to HER2 on the tumor cell surface, trastuzumab induces an antibody-dependent cell-mediated cytotoxicity against tumor cells that overexpress HER2. HER2 is overexpressed by many adenocarcinomas, particularly breast adenocarcinomas. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Agent","conceptCode":"C1708","definition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD0F852B-049E-7140-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-08-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-08-02","modifiedBy":"ONEDATA","dateModified":"2005-08-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207230","version":"1","preferredName":"Discontinued Administration","preferredDefinition":"Discontinued; stopped permanently or temporarily.:The act of administration.","longName":"C25484:C25409","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Discontinue","conceptCode":"C25484","definition":"To stop or end, permanently or temporarily.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Administration","conceptCode":"C25409","definition":"The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-1D15-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FD83EFA-69EC-E45F-E040-BB89AD43661F","latestVersionIndicator":"Yes","beginDate":"2010-09-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2010-09-09","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2390912","version":"1","preferredName":"National Surgical Adjuvant Breast and Bowel Project Treatment Not Administered Reason","preferredDefinition":"the trial-specific reason why treatment ended prematurely or did not begin.","longName":"NSABP_TX_N_ADMIN_RSN","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"130","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Unable to implant catheter/pump, or catheter/pump malfunction","valueDescription":"Unable to implant catheter/pump, or catheter/pump malfunction","ValueMeaning":{"publicId":"2575962","version":"1","preferredName":"Unable to implant catheter/pump, or catheter/pump malfunction","longName":"2575962","preferredDefinition":"Unable to implant catheter/pump, or catheter/pump malfunction","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F5C7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-08-22","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-08-22","modifiedBy":"SHIDED","dateModified":"2005-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FEEEAD2D-393C-2526-E034-0003BA3F9857","beginDate":"2005-08-22","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-08-22","modifiedBy":"ONEDATA","dateModified":"2005-08-22","deletedIndicator":"No"},{"value":"Treatment completed per protocol criteria","valueDescription":"Treatment completed per protocol criteria","ValueMeaning":{"publicId":"2570762","version":"1","preferredName":"Treatment completed per protocol criteria","longName":"2570762","preferredDefinition":"The formal plan of an experiment or research activity, including the objective, rationale, design, materials and methods for the conduct of the study; intervention description, and method of data analysis.: Indicates that the patient was fully compliant with the full course of treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Study Protocol","conceptCode":"C70817","definition":"The formal plan of an experiment or research activity, including the objective, rationale, design, materials and methods for the conduct of the study; intervention description, and method of data analysis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Treatment Completed as Prescribed","conceptCode":"C105740","definition":"Indicates that the patient was fully compliant with the full course of treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E177-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"LUY","dateModified":"2015-01-30","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 01/30/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FEEEAD2D-393F-2526-E034-0003BA3F9857","beginDate":"2005-08-22","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-08-22","modifiedBy":"ONEDATA","dateModified":"2005-08-22","deletedIndicator":"No"},{"value":"Adverse event/side effects/complications","valueDescription":"Adverse event/side effects/complications","ValueMeaning":{"publicId":"2563880","version":"1","preferredName":"Adverse event/side effects/complications","longName":"2563880","preferredDefinition":"Adverse event/side effects/complications","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C695-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-12-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FEEEAD2D-3942-2526-E034-0003BA3F9857","beginDate":"2005-08-22","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-08-22","modifiedBy":"ONEDATA","dateModified":"2005-08-22","deletedIndicator":"No"},{"value":"Patient withdrawal or refusal","valueDescription":"Patient withdrawal or refusal","ValueMeaning":{"publicId":"2569459","version":"1","preferredName":"Patient withdrawal or refusal","longName":"2569459","preferredDefinition":"An indication that a study participant has removed itself from the study.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: To decline to do, accept, give, or allow something.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Withdrawal by Subject","conceptCode":"C49634","definition":"An indication that a study participant has removed themself from the study or from one or more segments of the study.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Refuse","conceptCode":"C49161","definition":"To decline to do, accept, give, or allow something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DC60-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-04-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-04-28","modifiedBy":"LUY","dateModified":"2015-01-30","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 01/30/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FEEEAD2D-3944-2526-E034-0003BA3F9857","beginDate":"2005-08-22","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-08-22","modifiedBy":"ONEDATA","dateModified":"2005-08-22","deletedIndicator":"No"},{"value":"Alternative therapy","valueDescription":"Alternative Therapy","ValueMeaning":{"publicId":"2570086","version":"1","preferredName":"Alternative Therapy","longName":"2570086","preferredDefinition":"Forms of treatment that are used in addition to (complementary) or instead of (alternative) standard treatments. These practices generally are not considered standard medical approaches. Standard treatments go through a long and careful research process to prove they are safe and effective, but less is known about most types of CAM. CAM may include dietary supplements, megadose vitamins, herbal preparations, special teas, acupuncture, massage therapy, magnet therapy, spiritual healing, and meditation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Complementary and Alternative Medicine","conceptCode":"C15178","definition":"A group of diverse medical and health care systems, practices, and products that are not presently considered to be part of conventional medicine. Complementary medicine as being used together with conventional medicine, whereas alternative medicine is used in place of conventional medicine. The National Center for Complementary and Alternative Medicine (NCCAM) groups CAM practices into four domains, recognizing there can be some overlap: mind-body medicine; biologically based practices, manipulative and body-based practices, and energy medicine. In addition, NCCAM studies CAM whole medical systems, which cut across all domains.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DED3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"LUY","dateModified":"2015-01-30","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 01/30/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FEEEAD2D-3946-2526-E034-0003BA3F9857","beginDate":"2005-08-22","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-08-22","modifiedBy":"ONEDATA","dateModified":"2005-08-22","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2567790","version":"1","preferredName":"Other","longName":"2567790","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D5DB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"KUMMEROA","dateModified":"2023-11-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FEEF70D7-10B3-26FA-E034-0003BA3F9857","beginDate":"2005-08-22","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-08-22","modifiedBy":"ONEDATA","dateModified":"2005-08-22","deletedIndicator":"No"},{"value":"Death, recurrence, or second primary cancer","valueDescription":"Death, recurrence, or second primary cancer","ValueMeaning":{"publicId":"2569460","version":"1","preferredName":"Death, recurrence, or second primary cancer","longName":"2569460","preferredDefinition":"Death, recurrence, or second primary cancer","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DC61-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-04-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-04-28","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FEEF70D7-10B5-26FA-E034-0003BA3F9857","beginDate":"2005-08-22","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-08-22","modifiedBy":"ONEDATA","dateModified":"2005-08-22","deletedIndicator":"No"},{"value":"New lesion (including second primary cancer) or other sign of progression","valueDescription":"New lesion (including second primary cancer) or other sign of progression","ValueMeaning":{"publicId":"2580494","version":"1","preferredName":"New lesion (including second primary cancer) or other sign of progression","longName":"2580494","preferredDefinition":"New lesion (including second primary cancer) or other sign of progression","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-077B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-14","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-08-14","modifiedBy":"ALAIS","dateModified":"2006-08-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1AFC70C5-DA78-611A-E044-0003BA3F9857","beginDate":"2006-08-14","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-08-14","modifiedBy":"ONEDATA","dateModified":"2006-08-14","deletedIndicator":"No"},{"value":"Treatment Completed per Registration Program","valueDescription":"Treatment Completed per Registration Program","ValueMeaning":{"publicId":"2580256","version":"1","preferredName":"Treatment Completed per Registration Program","longName":"2580256","preferredDefinition":"Treatment Completed per Registration Program","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-068D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-14","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-07-14","modifiedBy":"ALAIS","dateModified":"2006-07-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"18911983-6DE6-583D-E044-0003BA3F9857","beginDate":"2006-07-14","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-07-14","modifiedBy":"ONEDATA","dateModified":"2006-07-14","deletedIndicator":"No"},{"value":"Other Adverse Event/Side Effects/Complications","valueDescription":"Other Adverse Event/Side Effects/Complications","ValueMeaning":{"publicId":"2571544","version":"1","preferredName":"Other Adverse Event/Side Effects/Complications","longName":"2571544","preferredDefinition":"Other Adverse Event/Side Effects/Complications","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E485-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-08-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-13","modifiedBy":"CAMPBELB","dateModified":"2004-08-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"18911983-6DF2-583D-E044-0003BA3F9857","beginDate":"2006-07-14","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-07-14","modifiedBy":"ONEDATA","dateModified":"2006-07-14","deletedIndicator":"No"},{"value":"Declining Bone Density/Osteoporotic Bone Fracture","valueDescription":"Declining Bone Density/Osteoporotic Bone Fracture","ValueMeaning":{"publicId":"2580257","version":"1","preferredName":"Declining Bone Density/Osteoporotic Bone Fracture","longName":"2580257","preferredDefinition":"Declining Bone Density/Osteoporotic Bone Fracture","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-068E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-14","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-07-14","modifiedBy":"ALAIS","dateModified":"2006-07-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"189171C1-E4BE-593A-E044-0003BA3F9857","beginDate":"2006-07-14","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-07-14","modifiedBy":"ONEDATA","dateModified":"2006-07-14","deletedIndicator":"No"},{"value":"Disease progression or relapse","valueDescription":"Disease progression or relapse","ValueMeaning":{"publicId":"2580258","version":"1","preferredName":"Disease progression or relapse","longName":"2580258","preferredDefinition":"Disease progression or relapse","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-068F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-14","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-07-14","modifiedBy":"ALAIS","dateModified":"2006-07-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"188FF9DD-CC05-583B-E044-0003BA3F9857","beginDate":"2006-07-14","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-07-14","modifiedBy":"ONEDATA","dateModified":"2006-07-14","deletedIndicator":"No"},{"value":"Death","valueDescription":"Death","ValueMeaning":{"publicId":"2567604","version":"1","preferredName":"Death","longName":"2567604","preferredDefinition":"The cessation of life.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dead","conceptCode":"C28554","definition":"The cessation of life.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D521-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"COOPERM","dateModified":"2015-11-24","changeDescription":"Added the NCIt concept definition as the System Generated definition per request by NMDP. mc 11/24/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"18910B53-6FF9-5277-E044-0003BA3F9857","beginDate":"2006-07-14","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-07-14","modifiedBy":"ONEDATA","dateModified":"2006-07-14","deletedIndicator":"No"},{"value":"Patient off-treatment for other complicating disease","valueDescription":"Patient off-treatment for other complicating disease","ValueMeaning":{"publicId":"2559741","version":"1","preferredName":"Patient off-treatment for other complicating disease","longName":"2559741","preferredDefinition":"Patient off-treatment for other complicating disease","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B66A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MAESKEB","dateModified":"2018-08-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"18910879-78A0-583F-E044-0003BA3F9857","beginDate":"2006-07-14","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-07-14","modifiedBy":"ONEDATA","dateModified":"2006-07-14","deletedIndicator":"No"},{"value":"Patient withdrawal or refusal for reason other than toxicity","valueDescription":"PATIENT WITHDRAWAL OR REFUSAL FOR REASON OTHER THAN TOXICITY","ValueMeaning":{"publicId":"2559752","version":"1","preferredName":"PATIENT WITHDRAWAL OR REFUSAL FOR REASON OTHER THAN TOXICITY","longName":"2559752","preferredDefinition":"PATIENT WITHDRAWAL OR REFUSAL FOR REASON OTHER THAN TOXICITY","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B675-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5B1D3D93-18CF-455D-E044-0003BA3F9857","beginDate":"2008-11-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-11-07","modifiedBy":"ONEDATA","dateModified":"2008-11-07","deletedIndicator":"No"},{"value":"Disease progression, relapse during active treatment","valueDescription":"Disease progression, relapse during active treatment","ValueMeaning":{"publicId":"2570249","version":"1","preferredName":"Disease progression, relapse during active treatment","longName":"2570249","preferredDefinition":"Disease progression, relapse during active treatment","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DF76-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5B1D2A34-67DB-4F6F-E044-0003BA3F9857","beginDate":"2008-11-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-11-07","modifiedBy":"ONEDATA","dateModified":"2008-11-07","deletedIndicator":"No"},{"value":"Death on study","valueDescription":"Death on Study","ValueMeaning":{"publicId":"2558597","version":"1","preferredName":"Death on Study","longName":"2558597","preferredDefinition":"Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, study of mechanisms of human diseases, therapy, clinical trials, epidemiologic, behavior, and health services research.: The cessation of life.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Study","conceptCode":"C15206","definition":"Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, study of mechanisms of human diseases, therapy, clinical trials, epidemiologic, behavior, and health services research.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Dead","conceptCode":"C28554","definition":"The cessation of life.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B1F2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2016-07-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5B1D2A34-67E6-4F6F-E044-0003BA3F9857","beginDate":"2008-11-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-11-07","modifiedBy":"ONEDATA","dateModified":"2008-11-07","deletedIndicator":"No"},{"value":"Patient withdrawal/refusal for reason other than toxicity","valueDescription":"PATIENT WITHDRAWAL OR REFUSAL FOR REASON OTHER THAN TOXICITY","ValueMeaning":{"publicId":"2559752","version":"1","preferredName":"PATIENT WITHDRAWAL OR REFUSAL FOR REASON OTHER THAN TOXICITY","longName":"2559752","preferredDefinition":"PATIENT WITHDRAWAL OR REFUSAL FOR REASON OTHER THAN TOXICITY","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B675-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"62986431-5D89-31B8-E040-BB89AD43427C","beginDate":"2008-11-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-10","modifiedBy":"ONEDATA","dateModified":"2009-02-10","deletedIndicator":"No"},{"value":"Patient withdrawal/refusal after beginning therapy","valueDescription":"Patient withdrawal/refusal after beginning therapy","ValueMeaning":{"publicId":"2944961","version":"1","preferredName":"Patient withdrawal/refusal after beginning therapy","longName":"2944961","preferredDefinition":"Patient withdrawal/refusal after beginning therapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7453519B-086D-45B4-E040-BB89AD4308B9","latestVersionIndicator":"Yes","beginDate":"2009-09-24","endDate":null,"createdBy":"SHIDED","dateCreated":"2009-09-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7453519B-0886-45B4-E040-BB89AD4308B9","beginDate":"2009-09-24","endDate":null,"createdBy":"SHIDED","dateCreated":"2009-09-24","modifiedBy":"ONEDATA","dateModified":"2009-09-24","deletedIndicator":"No"},{"value":"Disease progression, recurrence or second primary cancer","valueDescription":"Disease progression, recurrence or second primary cancer","ValueMeaning":{"publicId":"3107694","version":"1","preferredName":"Disease progression, recurrence or second primary cancer","longName":"3107694","preferredDefinition":"Disease progression, recurrence or second primary cancer","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"887591F7-2A70-BE99-E040-BB89AD4334F7","latestVersionIndicator":"Yes","beginDate":"2010-06-07","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"887591F7-2A89-BE99-E040-BB89AD4334F7","beginDate":"2010-06-07","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-07","modifiedBy":"ONEDATA","dateModified":"2010-06-07","deletedIndicator":"No"},{"value":"Physician withdrawal","valueDescription":"Physician withdrawal","ValueMeaning":{"publicId":"2569458","version":"1","preferredName":"Physician withdrawal","longName":"2569458","preferredDefinition":"Physician withdrawal","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DC5F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-04-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-04-28","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"887591F7-2A93-BE99-E040-BB89AD4334F7","beginDate":"2010-06-07","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-07","modifiedBy":"ONEDATA","dateModified":"2010-06-07","deletedIndicator":"No"},{"value":"Surgical complications","valueDescription":"Surgical complications","ValueMeaning":{"publicId":"2575328","version":"1","preferredName":"Surgical complications","longName":"2575328","preferredDefinition":"Surgical complications","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F34D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-06-13","modifiedBy":"SHIDED","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"887591F7-2A9D-BE99-E040-BB89AD4334F7","beginDate":"2010-06-07","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-07","modifiedBy":"ONEDATA","dateModified":"2010-06-07","deletedIndicator":"No"},{"value":"Toxicity/adverse event during therapy","valueDescription":"Toxicity/adverse event during therapy","ValueMeaning":{"publicId":"3107695","version":"1","preferredName":"Toxicity/adverse event during therapy","longName":"3107695","preferredDefinition":"Toxicity/adverse event during therapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"887591F7-2AA8-BE99-E040-BB89AD4334F7","latestVersionIndicator":"Yes","beginDate":"2010-06-07","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"887591F7-2AC1-BE99-E040-BB89AD4334F7","beginDate":"2010-06-07","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-07","modifiedBy":"ONEDATA","dateModified":"2010-06-07","deletedIndicator":"No"},{"value":"Recurrence or second primary cancer","valueDescription":"Recurrence or second primary cancer","ValueMeaning":{"publicId":"3166035","version":"1","preferredName":"Recurrence or second primary cancer","longName":"3166035","preferredDefinition":"The reemergence of a neoplasm after a period of remission: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A primary malignant neoplasm in a patient who has been already diagnosed with a primary malignant neoplasm in another anatomic site.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Recurrent Neoplasm","conceptCode":"C4798","definition":"The reemergence of a neoplasm after a period of remission.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Second Primary Malignant Neoplasm","conceptCode":"C95606","definition":"A primary malignant neoplasm in a patient who has been already diagnosed with a primary malignant neoplasm in another anatomic site.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9751FB3E-95A1-EBA5-E040-BB89AD432337","latestVersionIndicator":"Yes","beginDate":"2010-12-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-12-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 01/30/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9751FB3E-95BA-EBA5-E040-BB89AD432337","beginDate":"2010-12-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-12-13","modifiedBy":"ONEDATA","dateModified":"2010-12-13","deletedIndicator":"No"},{"value":"Non-protocol-specified toxicity/adverse event","valueDescription":"Non-protocol-specified toxicity/adverse event","ValueMeaning":{"publicId":"3163874","version":"1","preferredName":"Non-protocol-specified toxicity/adverse event","longName":"3163874","preferredDefinition":"Non-protocol-specified toxicity/adverse event","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9684E91A-136E-4ACC-E040-BB89AD430B1E","latestVersionIndicator":"Yes","beginDate":"2010-12-03","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-12-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9684E91A-1387-4ACC-E040-BB89AD430B1E","beginDate":"2010-12-03","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-12-03","modifiedBy":"ONEDATA","dateModified":"2010-12-03","deletedIndicator":"No"},{"value":"Protocol-specified toxicity/adverse event","valueDescription":"Protocol-specified toxicity/adverse event","ValueMeaning":{"publicId":"3163875","version":"1","preferredName":"Protocol-specified toxicity/adverse event","longName":"3163875","preferredDefinition":"Protocol-specified toxicity/adverse event","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9684E91A-1391-4ACC-E040-BB89AD430B1E","latestVersionIndicator":"Yes","beginDate":"2010-12-03","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-12-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9684E91A-13AA-4ACC-E040-BB89AD430B1E","beginDate":"2010-12-03","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-12-03","modifiedBy":"ONEDATA","dateModified":"2010-12-03","deletedIndicator":"No"},{"value":"Toxicity/adverse event","valueDescription":"Toxicity/adverse event","ValueMeaning":{"publicId":"3423459","version":"1","preferredName":"Toxicity/adverse event","longName":"3423459","preferredDefinition":"The finding of bodily harm due to the poisonous effects of something.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Any unfavorable or unintended symptom, sign, or disease including an abnormal laboratory finding) temporally associated with the use of a medical treatment or procedure that may or may not be considered related to the medical treatment or procedure.  Such events can be intervention related, dose related, route related, patient related, or caused by an interaction with another drug(s) or procedure(s).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Toxicity","conceptCode":"C27990","definition":"The finding of bodily harm due to the poisonous effects of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adverse Event","conceptCode":"C41331","definition":"Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BC500814-662A-853C-E040-BB89AD4336D2","latestVersionIndicator":"Yes","beginDate":"2012-03-28","endDate":null,"createdBy":"BRETTS","dateCreated":"2012-03-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 01/30/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BC500814-6643-853C-E040-BB89AD4336D2","beginDate":"2012-03-28","endDate":null,"createdBy":"BRETTS","dateCreated":"2012-03-28","modifiedBy":"ONEDATA","dateModified":"2012-03-28","deletedIndicator":"No"},{"value":"Lost to follow-up","valueDescription":"Lost to Follow-up","ValueMeaning":{"publicId":"2561825","version":"1","preferredName":"Lost to Follow-up","longName":"2561825v1.00","preferredDefinition":"The loss or lack of continuation of subject participation after a study has officially closed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lost To Follow-Up","conceptCode":"C48227","definition":"The loss or lack of continuation of subject participation after a study has officially closed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-BE8E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-07-10","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-10","modifiedBy":"KUMMEROA","dateModified":"2023-08-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B5A2A9F6-E3F8-515B-E040-BB89AD431E44","beginDate":"2012-01-03","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-03","modifiedBy":"ONEDATA","dateModified":"2012-01-03","deletedIndicator":"No"},{"value":"Non-compliance with protocol requirements","valueDescription":"Noncompliance with Protocol","ValueMeaning":{"publicId":"2572459","version":"1","preferredName":"Noncompliance with Protocol","longName":"2572459","preferredDefinition":"Noncompliance with Protocol","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E818-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-12-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-12-16","modifiedBy":"REEVESD","dateModified":"2004-12-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B5A2A9F6-E40C-515B-E040-BB89AD431E44","beginDate":"2012-01-03","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-03","modifiedBy":"ONEDATA","dateModified":"2012-01-03","deletedIndicator":"No"},{"value":"Disease Progression","valueDescription":"Disease Progression","ValueMeaning":{"publicId":"2816916","version":"1","preferredName":"Disease Progression","longName":"2816916","preferredDefinition":"The worsening of a disease over time","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease Progression","conceptCode":"C17747","definition":"A process that manifests as the worsening of a disease over time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5E58029E-1D6F-C9CD-E040-BB89A643215D","latestVersionIndicator":"Yes","beginDate":"2008-12-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-12-18","modifiedBy":"TSESU","dateModified":"2022-12-28","changeDescription":"Updated VM definitions to reflect change in NCIt concept definition. mc 10/31/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ED2064D8-11A1-E5BF-E040-BB89AD430969","beginDate":"2013-12-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2013-12-09","modifiedBy":"ONEDATA","dateModified":"2013-12-09","deletedIndicator":"No"},{"value":"Cytogenetic Resistance","valueDescription":"Cytogenetic resistance","ValueMeaning":{"publicId":"2563879","version":"1","preferredName":"Cytogenetic resistance","longName":"2563879","preferredDefinition":"The branch of biology that studies the cellular aspects of heredity, especially the chromosomes. Includes the study of disease states caused by numerical and structural chromosome abnormalities.: A Resistance Process consists of activities of biologic molecules or complexes involved in processes that maintain immunity to, or counteract, defeat, or withstand the effects of, an antagonistic agent.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytogenetics","conceptCode":"C16487","definition":"The branch of biology that studies the cellular aspects of heredity, especially the chromosomes. Includes the study of disease states caused by numerical and structural chromosome abnormalities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Resistance Process","conceptCode":"C41546","definition":"A Resistance Process consists of activities of biologic molecules or complexes involved in processes that maintain immunity to, or counteract, defeat, or withstand the effects of, an antagonistic agent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C694-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-12-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"REEVESD","dateModified":"2016-07-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ED2064D8-11F2-E5BF-E040-BB89AD430969","beginDate":"2013-12-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2013-12-09","modifiedBy":"ONEDATA","dateModified":"2013-12-09","deletedIndicator":"No"},{"value":"Symptomatic deterioriation","valueDescription":"Symptomatic deterioriation","ValueMeaning":{"publicId":"5978786","version":"1","preferredName":"Symptomatic deterioriation","longName":"5978786","preferredDefinition":"Symptomatic deterioriation","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5918B5E9-A703-5BF4-E053-F662850AFA80","latestVersionIndicator":"Yes","beginDate":"2017-09-13","endDate":null,"createdBy":"SARAHB","dateCreated":"2017-09-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5918B5E9-A71C-5BF4-E053-F662850AFA80","beginDate":"2017-09-13","endDate":null,"createdBy":"SARAHB","dateCreated":"2017-09-13","modifiedBy":"ONEDATA","dateModified":"2017-09-13","deletedIndicator":"No"},{"value":"Disease progression before active treatment","valueDescription":"Disease progression before active treatment","ValueMeaning":{"publicId":"2563881","version":"1","preferredName":"Disease progression before active treatment","longName":"2563881","preferredDefinition":"Disease progression before active treatment","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C696-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-12-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5918B5E9-A730-5BF4-E053-F662850AFA80","beginDate":"2017-09-13","endDate":null,"createdBy":"SARAHB","dateCreated":"2017-09-13","modifiedBy":"ONEDATA","dateModified":"2017-09-13","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008554","version":"1","preferredName":"Treatment/Off-treatment Reasons","preferredDefinition":"justification for or explanation of the administration or cessation of therapy.","longName":"TX_OTX_RSNS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2C9BE32-8BDB-649C-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2240632","version":"1","preferredName":"Reason","preferredDefinition":"An explanation of the cause of some phenomenon or action.","longName":"C25638","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F9FA7953-8391-043D-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-30","endDate":null,"createdBy":"PWEST","dateCreated":"2005-06-30","modifiedBy":"ONEDATA","dateModified":"2005-06-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NSABP CRF:National Surgical Adjuvant Breast and Bowel Project Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEEF70D7-109C-26FA-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-08-22","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-08-22","modifiedBy":"MAESKEB","dateModified":"2018-08-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Primary reason trastuzumab tr","type":"Preferred Question Text","description":"Primary reason trastuzumab treatment ended","url":null,"context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FD83EFA-6A0E-E45F-E040-BB89AD43661F","latestVersionIndicator":"Yes","beginDate":"2010-09-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2010-09-09","modifiedBy":"CAMPBELB","dateModified":"2010-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}